Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 2796

    Article Cited by others


Optimising 18 F-choline PET/CT acquisition protocol in prostate cancer patients

Massaro Arianna, Ferretti Alice, Secchiero Chiara, Cittadin Silvia, Milan Elisa, Tamiso Luca, Pavan Lara, Tommasi Enrico, Marzola Maria Cristina, Chondrogiannis Sotirios, Rampin Lucia, Marcolongo Adriano, Rubello Domenico

Year : 2012| Volume: 4| Issue : 9 | Page no: 416-420

   This article has been cited by
1 Optimization of temporal sampling for 18F-choline uptake quantification in prostate cancer assessment
Xavier Palard-Novello,Anne-Lise Blin,Florence Le Jeune,Etienne Garin,Pierre-Yves Salaün,Anne Devillers,Giulio Gambarota,Solène Querellou,Patrick Bourguet,Hervé Saint-Jalmes
EJNMMI Research. 2018; 8(1)
[Pubmed]  [Google Scholar] [DOI]
2 Comparison of 18F-Choline PET/CT and MRI functional parameters in prostate cancer
Xavier Palard-Novello,Luc Beuzit,Giulio Gambarota,Florence Le Jeune,Etienne Garin,Pierre-Yves Salaün,Anne Devillers,Solène Querellou,Patrick Bourguet,Hervé Saint-Jalmes
Annals of Nuclear Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 [18F]Fluoromisonidazole PET in rectal cancer
Tanuj Puri,Tessa A. Greenhalgh,James M. Wilson,Jamie Franklin,Lia Mun Wang,Victoria Strauss,Chris Cunningham,Mike Partridge,Tim Maughan
EJNMMI Research. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
4 Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis
Finn E. von Eyben,Kalevi Kairemo
Annals of Nuclear Medicine. 2016;
[Pubmed]  [Google Scholar] [DOI]
5 Dual-phase 18F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan
Aaron Tong Kian Ti,Zoe Zhang Xiaozhu,Zaheer Sumbul,Sean Yan Xuexian
Clinical Imaging. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 Impact and correction of the bladder uptake on18F-FCH PET quantification: a simulation study using the XCAT2 phantom
Jesús Silva-Rodríguez,Charalampos Tsoumpas,Inés Domínguez-Prado,Juan Pardo-Montero,Álvaro Ruibal,Pablo Aguiar
Physics in Medicine and Biology. 2016; 61(2): 758
[Pubmed]  [Google Scholar] [DOI]
7 Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence
Jose R. Garcia,Gemma Cuberas,Eduard Riera,Marina Soler,Merce Moragas,Francisco Lomeña
Nuclear Medicine Communications. 2015; 36(1): 8
[Pubmed]  [Google Scholar] [DOI]
8 Optimized Protocol for 18F-Choline PET/CT in Patients with Biochemically Relapsed Prostate Cancer
Sotirios Chondrogiannis,Maria Cristina Marzola,Gaia Grassetto,Lucia Rampin,Arianna Massaro,Patrick M. Colletti,Domenico Rubello
Clinical Nuclear Medicine. 2015; 40(6): e308
[Pubmed]  [Google Scholar] [DOI]
9 Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT?
Daniele Di Biagio,Agostino Chiaravalloti,Mario Tavolozza,Paolo Abbatiello,Orazio Schillaci
Annals of Nuclear Medicine. 2015; 29(10): 861
[Pubmed]  [Google Scholar] [DOI]
10 New Acquisition Protocol of18F-Choline PET/CT in Prostate Cancer Patients: Review of the Literature about Methodology and Proposal of Standardization
Sotirios Chondrogiannis,Maria Cristina Marzola,Gaia Grassetto,Anna Margherita Maffione,Lucia Rampin,Emma Veronese,Arianna Massaro,Domenico Rubello
BioMed Research International. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
11 F-18 Choline PET angiography of the pelvic arteries: evaluation of image quality and comparison with contrast-enhanced CT
Martin Freesmeyer,Robert Drescher
Clinical Imaging. 2014;
[Pubmed]  [Google Scholar] [DOI]
12 Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?
Sotirios Chondrogiannis,Maria Cristina Marzola,Alice Ferretti,Gaia Grassetto,Anna Margherita Maffione,Lucia Rampin,Stefano Fanti,Francesco Giammarile,Domenico Rubello
European Journal of Nuclear Medicine and Molecular Imaging. 2014;
[Pubmed]  [Google Scholar] [DOI]
13 Update on the use of radiopharmaceuticals for positron emission tomography imaging of prostate cancer
J.R. García
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 2013; 32(3): 177
[Pubmed]  [Google Scholar] [DOI]
14 First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy
Franz Buchegger,Valentina Garibotto,Thomas Zilli,Laurent Allainmat,Sandra Jorcano,Hansjörg Vees,Olivier Rager,Charles Steiner,Habib Zaidi,Yann Seimbille,Osman Ratib,Raymond Miralbell
European Journal of Nuclear Medicine and Molecular Imaging. 2013;
[Pubmed]  [Google Scholar] [DOI]
15 Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
Sotirios Chondrogiannis,Maria Cristina Marzola,Alice Ferretti,Anna Margherita Maffione,Lucia Rampin,Gaia Grassetto,Cristina Nanni,Patrick M. Colletti,Domenico Rubello
European Journal of Nuclear Medicine and Molecular Imaging. 2013; 40(9): 1356
[Pubmed]  [Google Scholar] [DOI]
16 PET Angiography: Application of Early Dynamic PET/CT to the Evaluation of Arteries
Robert Drescher,Martin Freesmeyer
American Journal of Roentgenology. 2013; 201(4): 908
[Pubmed]  [Google Scholar] [DOI]
17 Actualización del uso de radiofármacos en tomografía por emisión de positrones en el cáncer de próstata
J.R. García
Revista Española de Medicina Nuclear e Imagen Molecular. 2013; 32(3): 177
[Pubmed]  [Google Scholar] [DOI]
18 Update on the use of radiopharmaceuticals for positron emission tomography imaging of prostate cancer
García, J.R.
Revista Espanola de Medicina Nuclear e Imagen Molecular. 2013; 32(3): 177-186
[Pubmed]  [Google Scholar]


Read this article